ACG Updates Guidelines For Eosinophilic Oesophagitis Management
Jan 9, 2025 · THE LATEST clinical guidelines from the American College of Gastroenterology (ACG) aim to improve the diagnosis and treatment of eosinophilic oesophagitis (EoE), reflecting paradigm shifts and increases in knowledge from the past decade. EoE is a chronic immune-mediated disorder of the oesophagus ...
EMJ | Elevating the quality of healthcare globally
In this episode, Jonathan Sackier sits down with David Wan to discuss the latest advances in colorectal cancer screening, the importance of high-quality colonoscopy, and the emerging role of AI in polyp detection.
Stem-Cell Therapy Success in China Marks Milestone in Type 1 …
Nov 9, 2024 · IN A GROUNDBREAKING medical achievement, a 25-year-old woman with Type 1 diabetes (T1D) in China has successfully undergone a stem-cell therapy that enabled her to produce her own insulin, reducing her reliance on injections. The woman was treated with stem-cell-derived islet cells developed from her own fat cells, which were injected into her abdomen.
- [PDF]
Abstract Highlights
The following abstract highlights spotlight selected abstracts presented at the European Respiratory Society (ERS) Congress 2024. They cover key topics, including lung cancer screening
The Advances in Treatment Options for Conditions Causing Hair Loss
Nov 7, 2024 · DRUGS. Oral and topical JAK inhibitors have emerged as promising treatments for autoimmune-related hair loss, particularly alopecia areata. 3 JAK inhibitors function through inhibition of enzymes in the JAK/signal transducer and activator of transcription (STAT) signalling pathway, regulating immune system activity. Currently, three JAK inhibitors have been approved by the FDA for the ...
New CML Treatment Shows Promise, But Standard Therapy Endures
Oct 18, 2024 · The ASC4FIRST trial has shown asciminib, a novel BCR::ABL1 inhibitor, as a promising alternative to current tyrosine kinase inhibitors (TKIs) for chronic phase (CP) chronic myeloid leukaemia (CML). However, experts caution that the study’s design and outcomes raise significant questions, suggesting that imatinib, the original …
May 2, 2024 · Abbreviations: AML: acute myeloid leukemia; CCUS: clonal cytopenia of undetermined significance; del: deletion; EB: excess blasts; FISH: fluorescence in situ ...
Emetogenicity of Chemotherapy : MASCC/ESMO Guidelines - EMJ
Jun 16, 2022 · INTRODUCTION. CINV is experienced by about 70–80% of adult patients with cancer who are receiving chemotherapy, decreasing both quality of life and treatment compliance. 1-3 CINV remains one of the most feared side effects of chemotherapy, despite the availability of new and effective antiemetic medications. 4,5 With appropriate prophylaxis, vomiting can now be prevented in most patients ...
94 EMJ • March 2020 EMJ Diabetic Amyotrophy: From the Basics to the Bedside Authors: *James W. Albers,1 Ryan D. Jacobson, 2 David L. Smyth 1. University of Michigan Medical School, Ann Arbor, Michigan, USA
Only 1 serious opportunistic infection has occurred in DAYBREAK (a previously reported case of PML) 0 10 20 30 40 50 60 70 80 90 100 Any infection Serious infection